Antagonist-G

N/A

Report date: 2022/02/18 14:33:53
NME

Base Information

Drug NameAntagonist-G
Drug Alias NamePTL-68300BPTL-68001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsSmall Cell Lung CarcinomaPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Pharmaceutical Industries LtdCancer Research UK
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaPancreatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A